Actively Recruiting

Phase Not Applicable
Age: 6Years +
All Genders
Healthy Volunteers
NCT06544018

Circadian Rhythm Deregulation in Patients With CAPS

Led by Hospices Civils de Lyon · Updated on 2026-02-27

30

Participants Needed

6

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Circadian rhythms are characterized by the physiology's adaptation to the alternation of day and night, enabling to adapt to the environment. These rhythms are generated by a molecular clock within each cell. At the molecular level, the circadian clock is based on a complex system of cell-autonomous transcription loops. These exert positive and negative feedback on themselves, generating cyclic transcriptional activity. * In the main loop, the BMAL1 transcription factor links with CLOCK or NPAS2 ( (Neuronal PAS Domain Protein 2) to activate transcription of per1,2 and 3 and cryptochrome (cry1 and cry2), which in turn repress BMAL1/CLOCK1 transcriptional activity.. The BMAL1/CLOCK complex also activates transcription of numerous target genes (per and cry, Rev-erb, etc.).. * other secondary loops refine the function of the first. Recent studies suggest that many aspects of innate immunity are controlled by circadian rhythm through inhibition of NLRP3 inflammasome activation. Nevertheless, the regulation of the NLRP3 inflammasome by the circadian clock has yet to be elucidated. Inflammasomes are molecular platforms that control caspase-1 activation and consequently the maturation of precursors of (interleukine) IL-1β, pro-IL-18, a pro-inflammatory cytokine. Since its discovery, its functions have been widely characterized as part of the innate immune response as a sensor of pathogens and danger signals (extracellular ATP (Adenosine triphosphate), atmospheric pollutants). NLRP3 (nucleotide-binding domain LRR (leucin-rich repeat ) and pyrin-containing receptor 3) has been described for its genetic association with dominant monogenic hereditary syndromes characterized by recurrent systemic inflammatory episodes in the absence of any infection or autoimmune disease, known as CAPS (cryopyrin-associated periodic syndrome) or cryopyrinopathies which is a continuum of diseases ranging from a moderate to the most severe form of the syndrome: familial cold urticaria syndrome, Muckle-Wells syndrome (MWS), and CINCA/NOMID syndrome. Interestingly, patients with Muckle-Wells syndrome show a circadian pattern of symptoms, with a recurrent, predominantly vesperal fever peak lasting a few hours, and extreme fatigue on a daily basis. However, a molecular link between the circadian clock and CAPS pathology remains to be determined. The aim of this protocol is to identify circadian rhythm dysregulation in patients with CAPS confirmed by genetic analysis of NLRP3, to demonstrate a link between circadian clock and CAPS syndrome, and to identify circadian clock regulatory pathways.

CONDITIONS

Official Title

Circadian Rhythm Deregulation in Patients With CAPS

Who Can Participate

Age: 6Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 6 years and older
  • CAPS diagnosis confirmed by genetic analysis of NLRP3 (for CAPS group)
  • Weight 25 kilograms or more
  • Parents or guardians have provided informed consent
  • Patient or participant is affiliated with a social security scheme
  • For the control group: participant lives in the same household as a CAPS patient and has no CAPS symptoms (agrees to genetic testing)
Not Eligible

You will not qualify if you...

  • Chronic sleep disorders requiring medication such as sleeping pills or melatonin
  • Sleep apnea syndrome
  • Working regular night shifts or alternating day and night shifts
  • Pregnancy or breastfeeding
  • Parents with an infant under 6 months old
  • Participation in another interventional drug study
  • Legal deprivation of civil rights (curatorship or guardianship)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Hôpital Femme-Mère-Enfant (HCL)

Bron, France, 69677

Actively Recruiting

2

Hôpital Claude Huriez (CHU de Lille)

Lille, France, 59037

Not Yet Recruiting

3

Hôpital de la Croix-Rousse (HCL)

Lyon, France, 69004

Not Yet Recruiting

4

Hôpital Edouard Herriot (HCL)

Lyon, France, 69437

Not Yet Recruiting

5

Hôpital Tenon (AP-HP)

Paris, France, 75020

Not Yet Recruiting

6

Hôpital Kremlin-Bicêtre (AP-HP)

Paris, France, 94270

Not Yet Recruiting

Loading map...

Research Team

A

Alexandre Alexandre, PR

CONTACT

S

Samira Plassart

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here